Literature DB >> 6373808

The value of measuring severity of disease in clinical research on acutely ill patients.

W A Knaus, D P Wagner, E A Draper.   

Abstract

There are five major factors that determine outcome from disease: (1) disease type, (2) the severity of the disease, (3) the patient's age, (4) his prior health status, and (5) the therapy available. Evaluation of new treatments for various diseases is often done with little information on individual patients' severity. The most widely used method of controlling for acute severity fails to account for interaction among major organ systems and for important threshold effects found within physiologic measurements. To illustrate, we simulated a clinical trial comparing severity and outcome for two groups randomly chosen from 50 consecutive respiratory failure patients. Mean values for a variety of clinical, demographic, and physiologic measures were similar. A severity of disease classification, however, predicted differential mortality (25% vs 37%) that matched actual death rates. Uniform and accurate measurement of acute severity of disease in individual patients could improve the precision of clinical research.

Entities:  

Mesh:

Year:  1984        PMID: 6373808     DOI: 10.1016/0021-9681(84)90029-8

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  7 in total

Review 1.  Predicting outcome in critical care: the current status of the APACHE prognostic scoring system.

Authors:  D T Wong; W A Knaus
Journal:  Can J Anaesth       Date:  1991-04       Impact factor: 5.063

2.  Effects of SVM parameter optimization on discrimination and calibration for post-procedural PCI mortality.

Authors:  Michael E Matheny; Frederic S Resnic; Nipun Arora; Lucila Ohno-Machado
Journal:  J Biomed Inform       Date:  2007-05-18       Impact factor: 6.317

Review 3.  Scoring and outcome audit systems relevant to emergency medicine.

Authors:  M Waters; P Nightingale
Journal:  Arch Emerg Med       Date:  1990-03

4.  Cardiovascular parameters and scoring systems in the evaluation of response to therapy in sepsis and septic shock.

Authors:  G Pilz; K Werdan
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

5.  Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients.

Authors:  D Pittet; B Thiévent; R P Wenzel; N Li; G Gurman; P M Suter
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

6.  Evaluation of pediatric intensive care in Europe. A collaborative study by the European Club of Pediatric Intensive Care.

Authors:  F Beaufils; J C Roze; D Azema; G François Hamoir; D Bloc; D Floret; H Stopfkuchen; C C de Jong de Vos Van Steenwijk; E Van der Voort; F Mar Molinero
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

7.  Supplemental immunoglobulin (ivIgG) treatment in 163 patients with sepsis and septic shock--an observational study as a prerequisite for placebo-controlled clinical trials.

Authors:  G Pilz; S Kääb; G Neeser; I Class; U Schweigart; A Brähler; O Bujdoso; R Neumann; K Werdan
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.